|
January 30, 2012 |
Israel's RedHill Biopharma plans an advanced clinical trial for a once-a-day drug to prevent nausea and vomiting following cancer therapy.
Gilead Raday.
A relatively short clinical trial in Canada in 2012 is expected to speed along the process for potential approval of a new once-daily medication for the nausea and vomiting that's often a side effect of chemotherapy and radiation therapy for cancer.
The compound, for now dubbed RHB-102, was acquired by Israel's...
Read Full Story [Daily pill to vanquish nausea after chemo]
|